FIRST TIME?
CLAIM $30 OFF
Luscent Mask · Hybrid Photobiomodulation
Where Optical Precision Meets Clinical Depth
Four targeted wavelengths. One flexible silicone substrate. 236 LEDs and VCSEL laser diodes engineered to address every layer of skin biology, from the epidermis to subcutaneous tissue in ten minutes.
Optical Distribution
Precise Full-Face Coverage
The flexible curved design ensures even light distribution across the full facial surface — minimising wave loss and enhancing penetration around the eyes, nose, and jaw. No rigid plastic gaps. No optical decay at the periphery.
Deep Tissue Architecture
VCSEL Laser at 1064nm
Standard LED masks reach 3–5mm into tissue. The Luscent's VCSEL laser diodes operate at 1064nm — the clinical gold standard for reaching 5–10mm deep, targeting subcutaneous stem cells and structural collagen in layers LED-only devices cannot access.
Class 1 Laser Safety
20° Beam Angle. Eye-Safe
A precision 20-degree beam angle concentrates energy into tissue rather than scattering it. No goggles required. Certified Class 1 Laser Product — safe for daily home use without additional eyewear.
Material Engineering
Pure Comfort, Perfect Fit
Manufactured from nano-molecular food-grade silicone with a Flexible PCB and copper heat sinks to prevent wavelength drift. Contours to individual face geometry. Wireless, Type-C rechargeable. 1440mAh battery — full 10-minute sessions without power drop.
Tissue Penetration · Layered Targeting
Four Wavelengths. Four Biological Targets.
Regulatory Certifications · Verified
Ergonomic Design
Science perfected for comfort .
Made from nano-molecular food-grade silicone, the mask contours to your unique face geometry for consistent, full-contact light delivery. Wireless. Rechargeable. Breathable. Use reclining, working, or on the move.
- 880g · lightweight silicone construction
- 1440mAh battery · 1.5–2 hrs full charge use
- Type-C rechargeable · wireless operation
- 5 / 10 / 15 min timer · 3 brightness levels
- Silicone + FPCB copper heat sinks
Clinical depth in Ten minutes.
FDA Cleared · 236 LEDs + VCSEL · 4 Wavelengths
These statements have not been evaluated by the Therapeutic Goods Administration or Food and Drug Administration as treatment claims. This device is not intended to diagnose, treat, cure or prevent any disease. Results may vary.
Research & Clinical Evidence · Published Studies
The science behind every session.
LED and laser photobiomodulation is one of the most studied non-invasive skin interventions. The wavelengths used in Luscent Mask — 460nm, 665nm, 850nm, and 1064nm — are supported by peer-reviewed clinical literature. Below is a summary of the key studies informing the device's design.
Wound Recovery | 665nm · 850nm · Blue
Combined LED Therapy on Skin Wound Recovery
SOLIMAN ET AL. · PEER-REVIWED
-
Combined red, blue, and near-infrared LED therapy administered to 25 volunteers with active skin wounds. The study measured multiple outcome markers including wrinkle depth, elasticity scores, smoothness, and skin cell oxygenation across a multi-week protocol.
-
- Reduced Wrinkle depth
- Improved Skin Elasticity
- Enhanced Smoothness & Firmness
- Increased O₂ & Nutrient Delivery
Post-Surgical Scarring | Red LED
Red LED Phototherapy for Facial Post-Surgical Scar Reduction
KURTTI ET AL. · PEER-REVIEWED
-
30 patients treated with red LED (LED-RL) phototherapy in the early postoperative period on facial skin. Three energy doses tested: low (160 J/cm²), medium (320 J/cm²), and high (480 J/cm²), applied 3× weekly for 3 weeks. Low and medium doses showed the best scarring outcomes.
-
- 30 Patients Treated
- 3 Weeks Treatment Duration
- Safe Early Post-Op Use
- Reduced Post-Surgical Scarring
Acne Vulgaris | 415nm · 633nm
Blue and Red LED for Mild-to-Moderate Inflammatory Acne
LEE ET AL. · PEER-REVIEWED
-
Blue (415nm) and red (633nm) LED light therapy assessed in 24 patients with mild-to-moderate inflammatory acne vulgaris. Treatment delivered twice per week for 4 weeks. 14 of 24 patients showed clinically meaningful improvement — no adverse events recorded across the treatment period.
-
- 24 Patients Enrolled
- 14/24 Clinically Improved
- 2x / Week 4-Week Protocol
- No Adverse Events
Deep Tissue · 1064nm | VCSEL Laser
1064nm VCSEL and Stem Cell Viability in Subcutaneous Tissue
CLINICAL REVIEW LITERATURE · DEEP NIR PBM
-
Clinical reviews document that 1064nm irradiation maintains mesenchymal stem cell viability and increases concentrations of anti-inflammatory markers including IL-10. The 1064nm wavelength sits at the far end of the optical window where melanin and water absorption is low — enabling penetration to 5–10mm depth in subcutaneous tissue.
-
- 5-10mm Tissue Depth Reached
- Stem Cells Primary Target
- IL-10 Anti-Inflammatory Marker
- Fitzpatrick IV-VI Reduced Melanin Risk
All studies cited are peer-reviewed published literature. Luscent does not claim the device was used in these specific studies. These studies support the clinical rationale for the wavelengths deployed in the SR-M1 architecture. Individual results may vary. This device is not intended to diagnose, treat, cure or prevent any disease.
- Choosing a selection results in a full page refresh.
- Opens in a new window.
